Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Grant or award Director acquired 15,216 shares (grant or award)
  2. 4 Grant or award Director acquired 15,216 shares (grant or award)
  3. 4 Open-market sale GENERAL COUNSEL sold 5,475 shares at $6.97 ($38,161)
  4. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 4,297 shares at $6.97 ($29,950)
  5. 4 Grant or award Director acquired 15,216 shares (grant or award)
  6. 4 Grant or award Director acquired 15,216 shares (grant or award)
  7. 4 Grant or award Director acquired 15,216 shares (grant or award)
  8. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $8.71 ($10,313)
  9. 4 Grant or award Chief Financial Officer & PAO acquired 125,870 shares (grant or award)
  10. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $7.49 ($8,868)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $9.36 ($11,082)
  13. 4 Grant or award PRESIDENT AND CEO acquired 205,286 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4/A Grant or award CHIEF COMMERCIAL OFFICER acquired 69,100 shares (grant or award)
  16. 4/A Grant or award INTERIM CFO acquired 28,800 shares (grant or award)
  17. 4/A Grant or award GENERAL COUNSEL acquired 69,100 shares (grant or award)
  18. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 3,097 shares at $9.06 ($28,059)
  19. 4 Open-market sale INTERIM CFO sold 1,078 shares at $9.06 ($9,767)
  20. 4 Open-market sale GENERAL COUNSEL sold 4,351 shares at $9.06 ($39,420)

Page 4 of 12 · 229 filings